Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
Highlights
Remedy Meds acquires Thirty Madison in a $500M all-stock deal.
Salient Bio raises £2.35M to launch its IBD diagnostic test and focus on women’s health.
Danish startup Lapee raises €800K for women’s public urinals.
Fairtility receives FDA clearance for its AI-powered embryo assessment tool.
Perry launches a new academy to train healthcare providers in perimenopause care.
eIVF launches a new cloud-based EMR solution for fertility clinics.
Beverly Hills Fertility partners with controversial genetics company Nucleus Genomics.
In the Know
The State of PCOS Innovation: Where We Are (and Aren’t) Making Progress (Femtech Insider)
How THENA Capital Tackles the Challenges UK Medtech Founders Face Expanding to the US (Femtech Insider)
(When) Will AI Improve Women’s Health (Algorithm Watch)
The State of Global Femtech (BeautyMatter)
“Who Am I Without Birth Control?” (New York Times)
Paramedics are less likely to identify a stroke in women than men. Closing this gap could save lives – and money (The Conversation)
Who’s Hiring?
Below are some jobs we’ve curated for the women’s health innovation community this week.
Willbe is hiring a Head of Sales and Marketing.
Ellele Health is hiring a Partnership Manager.
Bloomlife is looking for a Chief Commercial Officer.
Gaia is looking for a Head of Product.
Carrot Fertility is hiring a Sr. Content Operations Specialist.
Maven Clinic is looking for a Senior Analyst Revenue Operations.
Cayaba Care is hiring a Vice President, Member Enrollment Operations.
Hims & Hers is looking for a Director, End-to-End Quality – Diagnostic Testing.
Progyny is hiring a Senior Product Manager.
To view more jobs, visit our job board. Are you hiring? Promote your role to our audience!
